Systems for fluid delivery with wicking membrane

Information

  • Patent Grant
  • 10449306
  • Patent Number
    10,449,306
  • Date Filed
    Wednesday, November 25, 2015
    9 years ago
  • Date Issued
    Tuesday, October 22, 2019
    6 years ago
Abstract
A fluid reservoir system is provided. The fluid reservoir system includes a fluid reservoir that defines a chamber to receive a fluid, and the fluid reservoir includes an outlet. The fluid reservoir system includes a source of pressure to draw the fluid into the outlet and a wicking membrane is coupled to the fluid reservoir that covers the outlet.
Description
TECHNICAL FIELD

Embodiments of the subject matter described herein relate generally to fluid infusion devices for delivering a medication fluid to the body of a user. More particularly, embodiments of the subject matter relate to systems for delivering fluid from a fluid reservoir with a wicking membrane.


BACKGROUND

Certain diseases or conditions may be treated, according to modern medical techniques, by delivering a medication or other substance to the body of a user, either in a continuous manner or at particular times or time intervals within an overall time period. For example, diabetes is commonly treated by delivering defined amounts of insulin to the user at appropriate times. Some common modes of providing insulin therapy to a user include delivery of insulin through manually operated syringes and insulin pens. Other modern systems employ programmable fluid infusion devices (e.g., insulin pumps) to deliver controlled amounts of insulin to a user.


A fluid infusion device suitable for use as an insulin pump may be realized as an external device or an implantable device, which is surgically implanted into the body of the user. External fluid infusion devices include devices designed for use in a generally stationary location (for example, in a hospital or clinic), and devices configured for ambulatory or portable use (to be carried by a user). External fluid infusion devices may establish a fluid flow path from a fluid reservoir to the patient via, for example, a suitable hollow tubing. In certain instances, during fluid delivery, air may become trapped within the fluid reservoir, which may affect fluid delivery accuracy.


Accordingly, it is desirable to provide systems for fluid delivery from a fluid reservoir with a wicking membrane, which ensures fluid delivery accuracy in instances where air may be trapped within the fluid reservoir. Furthermore, other desirable features and characteristics will become apparent from the subsequent detailed description and the appended claims, taken in conjunction with the accompanying drawings and the foregoing technical field and background.


BRIEF SUMMARY

According to the various teachings of the present disclosure, provided is a fluid reservoir system. The fluid reservoir system includes a fluid reservoir that defines a chamber to receive a fluid, and the fluid reservoir includes an outlet. The fluid reservoir system includes a source of pressure to draw the fluid into the outlet and a wicking membrane is coupled to the fluid reservoir that covers the outlet.


Further provided according to various embodiments is a fluid reservoir system. The fluid reservoir system includes a fluid reservoir that defines a chamber to receive a fluid, and the fluid reservoir includes an outlet that defines a fluid flow path. The fluid reservoir system also includes a source of pressure to dispense the fluid through the outlet. The fluid reservoir system includes a hydrophilic wicking membrane coupled to the fluid reservoir so as to be disposed within the chamber. The wicking membrane completely covers the outlet to substantially prevent a flow of air into the fluid flow path.


Also provided is a fluid infusion device. The fluid infusion device includes a fluid reservoir that defines a chamber to receive a fluid. The fluid reservoir includes a first end and a second end, with an outlet formed at the first end to define a fluid flow path. The fluid infusion device includes a drive system having a portion movable within the chamber to dispense the fluid through the outlet. The fluid infusion device also includes a hydrophilic wicking membrane coupled at the first end of the fluid reservoir so as to be disposed entirely within the chamber. The wicking membrane completely covers the outlet to substantially prevent a flow of air into the fluid flow path.


This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete understanding of the subject matter may be derived by referring to the detailed description and claims when considered in conjunction with the following figures, wherein like reference numbers refer to similar elements throughout the figures.



FIG. 1 is a perspective view of an exemplary embodiment of a fluid infusion device for fluid delivery with a wicking membrane according to various teachings of the present disclosure;



FIG. 1A is a top view of the fluid infusion device of FIG. 1;



FIG. 2 is cross-sectional view of the fluid infusion device of FIG. 1, taken along line 2-2 of FIG. 1A;



FIG. 3 is a perspective, partially cut-away view of a portion of a fluid reservoir system of the fluid infusion device of FIG. 1 according to an exemplary embodiment;



FIG. 4 is a perspective view of an exemplary embodiment of a fluid infusion device for fluid delivery with a wicking membrane according to various teachings of the present disclosure;



FIG. 5 is a cross-sectional view of the fluid infusion device of FIG. 4, taken along line 5-5 of FIG. 4;



FIG. 6 is a perspective view of an exemplary embodiment of a fluid infusion device for fluid delivery with a wicking membrane according to various teachings of the present disclosure; and



FIG. 7 is a cross-sectional view of the fluid infusion device of FIG. 6, taken along line 7-7 of FIG. 6.





DETAILED DESCRIPTION

The following detailed description is merely illustrative in nature and is not intended to limit the embodiments of the subject matter or the application and uses of such embodiments. As used herein, the word “exemplary” means “serving as an example, instance, or illustration.” Any implementation described herein as exemplary is not necessarily to be construed as preferred or advantageous over other implementations. Furthermore, there is no intention to be bound by any expressed or implied theory presented in the preceding technical field, background, brief summary or the following detailed description.


Certain terminology may be used in the following description for the purpose of reference only, and thus are not intended to be limiting. For example, terms such as “top”, “bottom”, “upper”, “lower”, “above”, and “below” could be used to refer to directions in the drawings to which reference is made. Terms such as “front”, “back”, “rear”, “side”, “outboard”, and “inboard” could be used to describe the orientation and/or location of portions of the component within a consistent but arbitrary frame of reference which is made clear by reference to the text and the associated drawings describing the component under discussion. Such terminology may include the words specifically mentioned above, derivatives thereof, and words of similar import. Similarly, the terms “first”, “second”, and other such numerical terms referring to structures do not imply a sequence or order unless clearly indicated by the context.


The following description relates to a fluid infusion device of the type used to treat a medical condition of a user. The infusion device can be used for infusing fluid into the body of a user. The non-limiting examples described below relate to a medical device used to treat diabetes (more specifically, an insulin pump), although embodiments of the disclosed subject matter are not so limited. Accordingly, the infused medication fluid is insulin in certain embodiments. In alternative embodiments, however, many other fluids may be administered through infusion such as, but not limited to, disease treatments, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, or the like. For the sake of brevity, conventional features and characteristics related to infusion system operation, insulin pump and/or infusion set operation, fluid reservoirs, and fluid syringes may not be described in detail here. Examples of infusion pumps and/or related pump drive systems used to administer insulin and other medications may be of the type described in, but not limited to: U.S. Patent Publication Nos. 2009/0299290 and 2008/0269687; U.S. Pat. Nos. 4,562,751; 4,678,408; 4,685,903; 5,080,653; 5,505,709; 5,097,122; 6,485,465; 6,554,798; 6,558,351; 6,659,980; 6,752,787; 6,817,990; 6,932,584; 7,621,893; 7,828,764; and 7,905,868; which are each incorporated by reference herein.



FIG. 1 is a perspective view of an exemplary embodiment of a fluid infusion device 100, and FIG. 1A is a top view of the fluid infusion device 100. In this example, the fluid infusion device 100 is designed to be carried or worn by the patient. The fluid infusion device 100 may leverage a number of conventional features, components, elements, and characteristics of existing fluid infusion devices. For example, the fluid infusion device 100 may incorporate some of the features, components, elements, and/or characteristics described in U.S. Pat. Nos. 6,485,465 and 7,621,893, the relevant content of which is incorporated by reference herein.


With reference to FIG. 1, the fluid infusion device 100 includes a user interface 102 and a display 104 coupled to a housing 106. The user interface 102 includes one or more user input devices, such as buttons, which can be activated by the user. The user interface 102 can be used to administer a bolus of insulin, to change therapy settings, to change user preferences, to select display features, and the like. Although not required, the illustrated embodiment of the fluid infusion device 100 includes the display 104. The display 104 can be used to present various types of information or data to the user, such as, without limitation: the current glucose level of the patient; the time; a graph or chart of the patient's glucose level versus time; device status indicators; etc. In some embodiments, the display 104 is realized as a touch screen display element and, therefore, the display 104 also serves as a user interface component.


With reference to FIG. 2, the housing 106 of the fluid infusion device 100 accommodates a power supply 110, a controller 112, a drive system 114, a seal 116 and a fluid reservoir system 118. Generally, the power supply 110, the controller 112, the drive system 114 and the seal 116 are accommodated in a pump chamber 106a defined by the housing 106, and the fluid reservoir system 118 is accommodated in a reservoir chamber 106b defined by the housing 106.


The power supply 110 is any suitable device for supplying the fluid infusion device 100 with power, including, but not limited to, a battery. In one example, the power supply 110 is removable relative to the housing 106; however, the power supply 110 may be fixed within the housing 106. The controller 112 is in communication with the user interface 102 (FIG. 1), the display 104 (FIG. 1), the power supply 110 and the drive system 114. The controller 112 controls the operation of the fluid infusion device 100 based on patient specific operating parameters. For example, the controller 112 controls the supply of power from the power supply 110 to the drive system 114 to activate the drive system 114 to dispense fluid from the fluid reservoir system 118. Further detail regarding the control of the fluid infusion device 100 can be found in U.S. Pat. Nos. 6,485,465 and 7,621,893, the relevant content of which was previously incorporated herein by reference.


The drive system 114 cooperates with the fluid reservoir system 118 to dispense the fluid from the fluid reservoir system 118. In one example, the drive system 114 includes a motor 122, a gear box 124, a drive screw 126 and a slide 128. The motor 122 receives power from the power supply 110. In one example, the motor 122 is an electric motor. The motor 122 includes an output shaft 130, which is coupled to the gear box 124. In one embodiment, the gear box 124 is a reduction gear box. The gear box 124 includes an output shaft 132, which is coupled to the drive screw 126.


The drive screw 126 includes a generally cylindrical distal portion 134 and a generally cylindrical proximal portion 136. The distal portion 134 includes a plurality of threads 138. The threads 138 are generally formed about an exterior circumference of the distal portion 134. The proximal portion 136 is generally unthreaded, and is sized to be received within a portion of the slide 128. Thus, the proximal portion 136 serves to align the drive screw 126 within the slide 128 during assembly, for example.


With continued reference to FIG. 2, the slide 128 is substantially cylindrical and includes a distal slide end 140, a proximal slide end 142 and a plurality of threads 144. The distal slide end 140 is adjacent to the motor 122 when the slide 128 is in a first, fully retracted position and the proximal slide end 142 is adjacent to the drive screw 126 when the slide 128 is in the first, fully retracted position. The proximal slide end 142 includes a projection 146 and a shoulder 147, which cooperate with the fluid reservoir system 118 to dispense the fluid from the fluid reservoir system 118. In one example, the projection 146 has a diameter that is smaller than a diameter of a remainder of the slide 128. It should be noted that the use of the projection 146 is merely exemplary, as the slide 128 need not include a projection 146 such that the proximal slide end 142 can be flat or planar. The shoulder 147 is defined adjacent to the projection 146 and contacts a portion of the fluid reservoir system 118 to dispense fluid from the fluid reservoir system 118, as will be discussed in greater detail herein.


The plurality of threads 144 of the slide 128 are formed along an interior surface 128a of the slide 128 between the distal slide end 140 and the proximal slide end 142. Generally, the threads 144 do not extend into the projection 146 of the proximal slide end 142. The threads 144 are formed so as to threadably engage the threads 138 of the drive screw 126. Thus, the rotation of the drive screw 126 causes the linear translation of the slide 128.


In this regard, the slide 128 is generally sized such that in a first, retracted position, the motor 122, the gear box 124 and the drive screw 126 are substantially surrounded by the slide 128. The slide 128 is movable to a second, fully extended position through the operation of the motor 122. The slide 128 is also movable to a plurality of positions between the first, retracted position and the second, fully extended position via the operation of the motor 122. Generally, the operation of the motor 122 rotates the output shaft 130, which is coupled to the gear box 124. The gear box 124 reduces the torque output by the motor 122, and the output shaft 132 of the gear box 124 rotates the drive screw 126, which moves along the threads 144 formed within the slide 128. The movement or rotation of the drive screw 126 relative to the slide 128 causes the movement or linear translation of the slide 128 within the housing 106. The advancement of the slide 128 into a portion of the fluid reservoir system 118 causes the fluid reservoir system 118 to dispense fluid.


With reference to FIG. 2, the seal 116 is disposed adjacent to the slide 128 and the reservoir chamber 106b. The seal 116 serves to separate the pump chamber 106a of the housing 106 from the reservoir chamber 106b to prevent the ingress of fluids to the motor 122, the gear box 124 and the drive screw 126 of the drive system 114. Generally, the seal 116 is positioned circumferentially about the slide 128 and defines an opening 150 through which the slide 128 moves.


The fluid reservoir system 118 includes a reservoir cap or connector body 154 and a fluid reservoir 156. The connector body 154 creates a fluid path from the fluid reservoir 156 to the body of the patient. In one exemplary embodiment, the connector body 154 is removably coupled to the housing 106, through any suitable technique, such as threads, press-fitting, etc. Generally, the connector body 154 is suitably sized and configured to accommodate the replacement of fluid reservoirs 156 (which are typically disposable) as needed. A sealing member, such as an O-ring 157 may be coupled between the connector body 154 and the reservoir chamber 106b to prevent the ingress of fluids into the reservoir chamber 106b of the housing 106.


In one example, the connector body 154 accommodates the fluid path from the fluid reservoir 156 to a tubing 158. The tubing 158 represents the fluid flow path that couples the fluid reservoir 156 to an infusion unit to deliver the fluid to the patient (not shown). In one example, the tubing 158 is coupled to the fluid reservoir 156 via a connector needle 160, which is coupled to the connector body 154 and pierces a septum 162 associated with the fluid reservoir 156. It should be noted, however, that any suitable technique could be employed to create a fluid path from the fluid reservoir 156 to the patient, and thus, this embodiment is merely an example.


In one example, the fluid reservoir 156 includes a body or barrel 170, a stopper 172 and a wicking membrane 174. The barrel 170 has a first or distal barrel end 176 and a second or proximal barrel end 178. The barrel 170 defines a fluid chamber for retaining the fluid F. The fluid F is retained within the barrel 170 between the distal barrel end 176 and the proximal barrel end 178. The distal barrel end 176 is positioned adjacent to the slide 128 when the fluid reservoir 156 is assembled in the housing 106. Generally, the distal barrel end 176 has an open perimeter or is circumferentially open such that the slide 128 is receivable within the barrel 170 through the distal barrel end 176. The proximal barrel end 178 defines a port 178a, which receives the connector needle 160 to establish the fluid flow path. The proximal barrel end 178 has any desired shape that mates with at least a portion of the connector body 154.


The stopper 172 is disposed within the barrel 170. The stopper 172 is movable within and relative to the barrel 170 to dispense fluid from the fluid reservoir 156. Stated another way, the stopper 172 is movable within the barrel 170 to pressurize the fluid such that the fluid flows from the barrel 170 through the port 178a into the connector needle 160 and the tubing 158. Thus, the stopper 172 and the drive system 114 cooperate to form a source of pressure for the fluid reservoir system 118. When the barrel 170 is full of fluid, the stopper 172 is adjacent to the distal barrel end 176, and the stopper 172 is movable to a position adjacent to the proximal barrel end 178 to empty the fluid from the fluid reservoir 156. In one example, the stopper 172 is substantially cylindrical, and includes a distal stopper end 180, a proximal stopper end 182, at least one friction element 184 and a counterbore 186 defined from the distal stopper end 180 to the proximal stopper end 182.


The distal stopper end 180 is open about a perimeter of the distal stopper end 180, and thus, is generally circumferentially open. The proximal stopper end 182 is closed about a perimeter of the proximal stopper end 182 and is generally circumferentially closed. The proximal stopper end 182 includes a slightly conical external surface; however, the proximal stopper end 182 can be flat, convex, etc. The at least one friction element 184 is coupled to the stopper 172 about an exterior surface 172a of the stopper 172. In one example, the at least one friction element 184 comprises two friction elements, which include, but are not limited to, O-rings. The friction elements 184 are coupled to circumferential grooves 188 defined in the exterior surface 172a of the stopper 172.


The counterbore 186 receives the projection 146 of the slide 128 and the movement of the slide 128 causes the shoulder 147 of the slide 128 to contact and move the stopper 172. In one example, the counterbore 186 includes threads 190; however, the projection 146 of the slide 128 is not threadably engaged with the stopper 172. Thus, the threads 190 illustrated herein are merely exemplary.


The wicking membrane 174 is coupled within the barrel 170 of the fluid reservoir 156. The wicking membrane 174 is generally coupled to the barrel 170 so as to completely cover an outlet 200 in the barrel 170 defined by the port 178a. The wicking membrane 174 completely covers the outlet 200 to substantially prevent the flow of air into the fluid flow path defined by the outlet 200, the port 178a and the tubing 158. In this example, the wicking membrane 174 is coupled to the barrel 170 at the proximal barrel end 178 such that the entirety of the wicking membrane 174 is disposed in the fluid chamber defined within the barrel 170. It will be understood, however, that the wicking membrane 174 may be coupled to the fluid reservoir 156 such that only the outlet 200 is covered by the wicking membrane 174. Moreover, it should be understood that the wicking membrane 174 may be coupled to the barrel 170 so as to extend from the proximal barrel end 178 to a point located between the proximal barrel end 178 and the distal barrel end 176, if desired. Thus, the wicking membrane 174 as illustrated herein is merely an example.


The wicking membrane 174 includes a first surface 202 substantially opposite a second surface 204. The first surface 202 is disposed within the barrel 170 so as to be in contact with and wetted by the fluid F. The second surface 204 is coupled to an interior surface 170a of the barrel 170 via any suitable technique, such as ultrasonic welding, adhesives, thermal bonding, mechanical fastening (e.g. staples, stitches), etc. Generally, the wicking membrane 174 is coupled to the barrel 170 so as to be fixedly or non-removably coupled to the barrel 170. The wicking membrane 174 may have a substantially small thickness, such as about 0.0762 millimeters (mm) or about 0.003 inches (in.). In this example, the wicking membrane 174 is coupled at the proximal barrel end 178 to enable the stopper 172 to be advanced to the proximal barrel end 178 without contact between the one or more friction elements 184 and the wicking membrane 174. It will be understood, however, that the stopper 172 may be configured to be advanced over a portion of the wicking membrane 174, if desired.


In one example, the wicking membrane 174 is a hydrophilic wicking membrane that draws the fluid F towards the outlet 200 via capillary action. The wicking membrane 174 enables the fluid F to flow from the barrel 170 through the port 178a, while inhibiting or preventing air from exiting through the port 178a. Thus, the wicking membrane 174 may comprise any suitable membrane that enables the passage of a liquid, such as the fluid F, through the membrane via capillary action, while substantially inhibiting the passage of air through the membrane. The first surface 202 of the wicking membrane 174, when wetted by the fluid F, draws the fluid F up through the wicking membrane 174 across a small volume of air due to the surface tension of the fluid F. The first surface 202 may be wetted by the fluid F within the fluid reservoir 156 during the normal use and operation of the fluid reservoir 156.


A pressure difference between the barrel 170 and the tubing 158 also assists the wicking membrane 174 in drawing the liquid or fluid F within the barrel 170 to the port 178a. In this regard, as a pressure within the barrel 170 is higher than a pressure in the tubing 158, the fluid F in the barrel 170 in contact with the first surface 202 of the wicking membrane 174 will be drawn up through the wicking membrane 174 via capillary action through the outlet 200 and out the port 178a.


The wicking membrane 174 may have any suitable pore size to assist in drawing the fluid F through the first surface 202 of the wicking membrane 174 while inhibiting the passage of air through the wicking membrane 174. In one example, the pore size ranges from about 0.1 micrometers (μm) to about 35.0 micrometers (μm). It should be noted that the wicking membrane 174 may have any desired pore size, and moreover, that the pore size may vary over portions of the wicking membrane 174 if desired. Generally, as the average pore size for the wicking membrane 174 decreases, the pressure differential between the barrel 170 and the port 178a required to disrupt the wetted first surface 202 increases (which decreases the likelihood of the introduction of air into the port 178a) and for a given pressure differential the flow rate of the fluid F through the wicking membrane 174 decreases. Thus, the pore size of the wicking membrane 174 may be dependent on the pressure differential between the fluid reservoir 156 and the tubing 158, the surface tension of the fluid F and a desired flow rate for the fluid F. The pore size selected for the wicking membrane 174 may also be dependent on the viscosity of the fluid F, the density of the fluid F, the surface angle between the wicking membrane 174 and the fluid F and the height of the port 178a above a surface of the fluid F. An exemplary hydrophilic wicking membrane 174 for use with the fluid reservoir 156 may comprise about a 0.330 millimeter (mm) or about 0.013 inches (in.) thick fiber membrane with an average pore size of about 5.0 micrometers (μm).


It should be noted that while the wicking membrane 174 is described and illustrated herein as comprising a membrane, the wicking membrane 174 need not be a membrane. In this regard, a series of micro-channels having hydrophilic inner surfaces may be defined or formed in the barrel 170 near the outlet 200. Thus, the wicking membrane 174 is merely an example.


With continued reference to FIG. 2, with the housing 106 assembled with the power supply 110, the controller 112 and the drive system 114, the fluid reservoir system 118 is coupled to the housing 106 with the wicking membrane 174 coupled at the proximal barrel end 178. Generally, a full fluid reservoir 156 is inserted into the reservoir chamber 106b of the housing 106 such that the stopper 172 is adjacent to the projection 146 of the slide 128. As the drive screw 126 rotates, the slide 128 translates linearly. The advancement of the slide 128 decreases an available volume within the barrel 170, which results in an increase in pressure in the barrel 170.


The pressure increase in the barrel 170 causes a pressure differential between the fluid reservoir 156 and the tubing 158, which is generally at an ambient pressure. The pressure differential assists in dispensing fluid F from the barrel 170 by drawing the fluid F into the tubing 158. Thus, the pressure increase in the barrel 170 acts as a source of positive pressure on the fluid reservoir 156 to draw the fluid into the outlet 200 and cooperates with the wicking membrane 174 to dispense the fluid F from the fluid reservoir 156 with substantially no air entering the outlet 200. With reference to FIG. 3, the pressure differential also assists the wicking membrane 174 in wicking the fluid F over air 206 disposed or trapped within the barrel 170. In this regard, with the second surface 204 coupled to the barrel 170 at the proximal barrel end 178 such that the wicking membrane 174 covers the outlet 200 and the fluid F in contact with the first surface 202, the fluid F may be drawn up into the outlet 200 via the capillary action of the wicking membrane 174. The surface tension of the fluid F enables the fluid F to flow out of the outlet 200 into the port 178a with substantially none of the air 206 exiting the barrel 170. By preventing the air 206 from exiting the fluid reservoir 156, the wicking membrane 174 improves fluid volume delivery accuracy. Thus, the fluid reservoir system 118 enables the fluid F in the fluid reservoir 156 to bypass the air 206 trapped in the barrel 170 such that substantially little to no air enters the fluid flow path defined by the connector needle 160 and tubing 158.


With reference now to FIGS. 4 and 5, a fluid reservoir system 300 is shown. As the fluid reservoir system 300 may be similar to the fluid reservoir system 118 discussed with regard to FIGS. 1-3, the same reference numerals will be used to denote the same or similar components.


In this example, the fluid reservoir system 300 comprises a semi-flexible fluid reservoir 302, which may employ a wicking membrane 301 (FIG. 5) similar to the wicking membrane 174 of FIGS. 1-3. The fluid reservoir 302 is operable to dispense fluid F or create a fluid flow path from the fluid reservoir 302 through a suitable hollow tubing 304. As discussed with regard to FIGS. 1-3, the fluid dispensed by the fluid reservoir system 300 may comprise any suitable fluid, including, but not limited to, disease treatments, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, insulin or the like. The fluid reservoir system 300 may comprise a stand-alone system for the dispensing of fluid to a patient, or may comprise a portion of a fluid infusion device.


In one example, with reference to FIG. 5, the tubing 304 is coupled to a source of pressure to draw the fluid from the fluid reservoir 302. For example, the tubing 304 is coupled to a source of a negative pressure 306, which creates a pressure differential between the fluid reservoir 302 and the tubing 304 to draw the fluid into the tubing 304. The source of negative pressure 306 may comprise any suitable negative pressure source, such as an in-line pumping system, including, but not limited to a peristaltic pump, a piston pump or the like. A suitable coupling or infusion set may be fluidly coupled downstream from the source of negative pressure 306 to deliver the fluid F to a patient, for example.


In this example, the fluid reservoir 302 includes a first, rigid reservoir wall 308 and a second, flexible reservoir wall 310. The rigid reservoir wall 308 may be composed of any suitable material, for example, a biocompatible polymeric material. The second, flexible reservoir wall 310 may be composed of a suitable flexible material, or a material that has greater flexibility than that of the rigid reservoir wall 308, including, but not limited to a flexible biocompatible material, such as a biocompatible polymer. The flexible reservoir wall 310 is coupled to the rigid reservoir wall 308 between a first or proximal end 312 and a second or distal end 314 of the rigid reservoir wall 308. Generally, the flexible reservoir wall 310 is coupled to the rigid reservoir wall 308 so as to define a fluid chamber 316. It should be noted that while the fluid reservoir 302 is illustrated herein as comprising the rigid reservoir wall 308 and the flexible reservoir wall 310, the fluid reservoir 302 may comprise any number of walls to define a fluid chamber. The fluid chamber 316 receives and contains the fluid F for dispensing.


The rigid reservoir wall 308 also includes an outlet 318. The outlet 318 is defined through the rigid reservoir wall 308 so as to enable fluid communication between the tubing 304 and the fluid chamber 316. The wicking membrane 301 is coupled to the rigid reservoir wall 308 so as to completely cover the outlet 318. The wicking membrane 301 completely covers the outlet 318 to substantially prevent the flow of air 206 into the fluid flow path defined by the outlet 318 and the tubing 304. In this example, the wicking membrane 301 extends from the proximal end 312 of the rigid reservoir wall 308 to a point 319 located near the distal end 314. The wicking membrane 301 is coupled to the rigid reservoir wall 308 such that the entirety of the wicking membrane 301 is disposed in the fluid chamber 316. By covering substantially an entirety of the rigid reservoir wall 308, the wicking membrane 301 assists in wicking the fluid F when the fluid chamber 316 has a low fluid level.


The wicking membrane 301 is coupled to the rigid reservoir wall 308 within the fluid chamber 316. The wicking membrane 301 includes a first surface 320 substantially opposite a second surface 322. The first surface 320 is disposed within the fluid chamber 316 so as to be in contact with and wetted by the fluid F. The second surface 322 is coupled to the rigid reservoir wall 308 via any suitable technique, such as ultrasonic welding, adhesives, thermal bonding, mechanical fastening (e.g. staples, stitches), etc. Generally, the wicking membrane 301 is coupled to the rigid reservoir wall 308 so as to be fixedly or non-removably coupled to the rigid reservoir wall 308. The wicking membrane 301 may also include one or more contours 301a, 301b formed at a first end of the wicking membrane 301 or formed to be adjacent to the outlet 318 when the wicking membrane 301 is coupled to the outlet 318. The contours 301a, 301b may assist in directing a flow of the fluid F from the fluid chamber 316 to the outlet 318.


In one example, the wicking membrane 301 is a hydrophilic wicking membrane that draws fluid via capillary action. The wicking membrane 301 enables the fluid F to flow from the fluid chamber 316 through the outlet 318, while inhibiting or preventing air from exiting through the outlet 318. Thus, the wicking membrane 301 may comprise any suitable membrane that enables the passage of a liquid, such as the fluid F, through the membrane via capillary action, while substantially inhibiting the passage of air through the membrane. The first surface 320 of the wicking membrane 301, when wetted by the fluid F, draws the fluid F up through the wicking membrane 301 across a small volume of air due to the surface tension of the fluid F. The first surface 320 may be wetted by the fluid F within the fluid chamber 316 during the normal use and operation of the fluid chamber 316.


Generally, the pressure difference between the fluid chamber 316 and the tubing 304 created by the source of negative pressure 306 assists the wicking membrane 301 in drawing the liquid or fluid F within the fluid chamber 316 to the outlet 318. In this regard, as a pressure within the fluid chamber 316 is greater than a pressure in the tubing 304, the fluid F in the fluid chamber 316 in contact with the first surface 320 of the wicking membrane 301 will be drawn up through the wicking membrane 301 and out the outlet 318 into the tubing 304. Thus, the source of negative pressure 306 acts on the fluid reservoir 302 to draw the fluid F into the outlet 318 and cooperates with the wicking membrane 301 to dispense the fluid F from the fluid reservoir 302 with substantially no air entering the outlet 318.


The wicking membrane 301 may have any suitable pore size to assist in drawing the fluid F through the first surface 320 of the wicking membrane 301 while inhibiting the passage of air through the wicking membrane 301. In one example, the pore size ranges from about 0.1 micrometers (μm) to about 35.0 micrometers (μm). It should be noted that the wicking membrane 301 may have any desired pore size, and moreover, that the pore size may vary over portions of the wicking membrane 301 if desired. Thus, the pore size of the wicking membrane 301 may be dependent on the pressure differential between the fluid chamber 316 and the tubing 304, the surface tension of the fluid F and a desired flow rate for the fluid F. The pore size selected for the wicking membrane 301 may also be dependent on the viscosity of the fluid F, the density of the fluid F, the surface angle between the wicking membrane 301 and the fluid F and the height of the outlet 318 above a surface of the fluid F. An exemplary hydrophilic wicking membrane 301 for use with the fluid chamber 316 may comprise about a 0.330 millimeter (mm) or about 0.013 inches (in.) thick fiber membrane with an average pore size of about 5.0 micrometers (μm).


It should be noted that while the wicking membrane 301 is described and illustrated herein as comprising a membrane, the wicking membrane 301 need not be a membrane. In this regard, a series of micro-channels having hydrophilic inner surfaces may be defined or formed on the rigid reservoir wall 308 near the outlet 318. Thus, the wicking membrane 301 is merely an example.


With the fluid reservoir system 300 assembled, and the fluid F disposed within the fluid chamber 316, the source of negative pressure 306 applies a negative pressure to the tubing 304. The negative pressure creates a pressure differential between the fluid chamber 316 and the tubing 304. The pressure differential assists in drawing the fluid F up through the wicking membrane 301, through the outlet 318 and into the tubing 304 and prevents substantially all of the air 206 from entering the outlet 318.


With reference now to FIGS. 6 and 7, a fluid reservoir system 400 is shown. As the fluid reservoir system 400 may be similar to the fluid reservoir system 300 discussed with regard to FIGS. 4 and 5, the same reference numerals will be used to denote the same or similar components.


In one example, the fluid reservoir system 400 comprises a fully flexible fluid reservoir 402, which may employ the wicking membrane 301. The fluid reservoir 402 is operable to dispense fluid F or create a fluid flow path from the fluid reservoir 402 through the tubing 304. The fluid dispensed by the fluid reservoir system 400 may comprise any suitable fluid, including, but not limited to, disease treatments, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, insulin or the like. The fluid reservoir system 400 may comprise a stand-alone system for the dispensing of fluid to a patient, or may comprise a portion of a fluid infusion device.


In one example, with reference to FIG. 7, the tubing 304 is coupled to the source of a negative pressure 306, which creates a pressure differential between the fluid reservoir 402 and the tubing 304. A suitable coupling or infusion set may be fluidly coupled downstream from the source of negative pressure 306 to deliver the fluid F to a patient, for example.


In this example, the fluid reservoir 402 includes a first, flexible reservoir wall 408 and the second, flexible reservoir wall 310. The first, flexible reservoir wall 408 and the second, flexible reservoir wall 310 may be composed of any suitable flexible material, for example, a flexible biocompatible polymeric material. The second, flexible reservoir wall 310 is coupled to the first, flexible reservoir wall 408 between a first or proximal end 412 and a second or distal end 414 of the first, flexible reservoir wall 408. Generally, the second, flexible reservoir wall 310 is coupled to the first, flexible reservoir wall 408 so as to define the fluid chamber 316. It should be noted that while the fluid reservoir 402 is illustrated herein as comprising the first, flexible reservoir wall 408 and the second, flexible reservoir wall 310, the fluid reservoir 402 may comprise any number of walls to define a fluid chamber. The fluid chamber 316 receives and contains the fluid F for dispensing.


The first, flexible reservoir wall 408 also includes an outlet 418. The outlet 418 is defined through the first, flexible reservoir wall 408 so as to enable fluid communication between the tubing 304 and the fluid chamber 316. The wicking membrane 301 is coupled to the first, flexible reservoir wall 408 so as to completely cover the outlet 418. The wicking membrane 301 completely covers the outlet 418 to substantially prevent the flow of air 206 into the fluid flow path defined by the outlet 418 and the tubing 304. The wicking membrane 301 is coupled to the first, flexible reservoir wall 408 such that the entirety of the wicking membrane 301 is disposed in the fluid chamber 316. In this example, the wicking membrane 301 extends from the proximal end 412 of the first, flexible reservoir wall 408 to a point 419 located near the distal end 414. By covering substantially an entirety of the first, flexible reservoir wall 408, the wicking membrane 301 assists in wicking the fluid F when the fluid chamber 316 has a low fluid level.


The wicking membrane 301 is coupled to the first, flexible reservoir wall 408 within the fluid chamber 316. The first surface 320 is disposed within the fluid chamber 316 so as to be in contact with and wetted by the fluid F. The second surface 322 is coupled to the first, flexible reservoir wall 408 via any suitable technique, such as ultrasonic welding, adhesives, thermal bonding, mechanical fastening (e.g. staples, stitches), etc. Generally, the wicking membrane 301 is coupled to the first, flexible reservoir wall 408 so as to be fixedly or non-removably coupled to the first, flexible reservoir wall 408. The wicking membrane 301 may also include the one or more contours 301a, 301b.


The wicking membrane 301 enables the fluid F to flow from the fluid chamber 316 through the outlet 418, while inhibiting or preventing air from exiting through the outlet 418. With the fluid reservoir system 400 assembled, and the fluid F disposed within the fluid chamber 316, the source of negative pressure 306 applies a negative pressure to the tubing 304. The negative pressure creates a pressure differential between the fluid chamber 316 and the tubing 304. The pressure differential assists in drawing the fluid F up through the wicking membrane 301, through the outlet 418 and into the tubing 304. Thus, the source of negative pressure 306 acts on the fluid reservoir 402 to draw the fluid F into the outlet 418 and cooperates with the wicking membrane 301 to dispense the fluid F from the fluid reservoir 402 with substantially no air entering the outlet 418. The wicking membrane 301 prevents substantially all of the air 206 from entering the outlet 418, and thereby improves fluid volume delivery accuracy.


While at least one exemplary embodiment has been presented in the foregoing detailed description, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or embodiments described herein are not intended to limit the scope, applicability, or configuration of the claimed subject matter in any way. Rather, the foregoing detailed description will provide those skilled in the art with a convenient road map for implementing the described embodiment or embodiments. It should be understood that various changes can be made in the function and arrangement of elements without departing from the scope defined by the claims, which includes known equivalents and foreseeable equivalents at the time of filing this patent application.

Claims
  • 1. A fluid infusion device, comprising: a housing having a first chamber and a second chamber, with a seal that separates the first chamber from the second chamber, and the seal defines an opening;a fluid reservoir removably received within the second chamber of the housing that defines a reservoir chamber to receive a fluid, the fluid reservoir including a first end and a second end, the first end having an open perimeter and the second end terminates in a port that includes an outlet, the fluid reservoir including a stopper disposed in the reservoir chamber that is movable from the first end to the second end to dispense the fluid through the outlet and the stopper has a distal stopper end opposite a proximal stopper end, with a counterbore defined through the distal stopper end, the fluid reservoir having a first pressure;a drive system received within the first chamber of the housing having a slide, a motor, a gear box and a drive screw, at least the gear box and the drive screw surrounded by the slide, the motor drives the gear box to rotate the drive screw, the slide including a plurality of threads defined on an interior surface that threadably engage threads of the drive screw such that a rotation of the drive screw by the gear box translates the slide through the opening of the seal into the second chamber, the slide received within the reservoir chamber through the first end of the fluid reservoir and translatable within the reservoir chamber, the slide having a projection received within the counterbore of the stopper and a shoulder that contacts the stopper to move the stopper from the first end to the second end to dispense the fluid into the outlet;a wicking membrane having a first surface in contact with the fluid and an opposite second surface, the second surface coupled to an interior surface of the fluid reservoir at the second end such that the wicking membrane completely covers the outlet to substantially prevent a flow of air into the outlet and the wicking membrane is spaced apart from the distal stopper end when the stopper is moved to the second end; anda reservoir cap removably coupled to the second chamber of the housing and including a connector needle received within the port downstream of the wicking membrane to define a fluid flow path from the fluid reservoir to a tubing, the tubing having a second pressure, the first pressure greater than the second pressure, and the difference between the first pressure and the second pressure cooperates with the wicking membrane to dispense the fluid through the outlet,wherein the stopper includes at least one friction element that contacts an interior surface of the fluid reservoir and the wicking membrane is coupled to the second end such that the at least one friction element is spaced apart from the wicking membrane when the stopper is moved to the second end.
  • 2. The fluid infusion device of claim 1, wherein the wicking membrane is a hydrophilic membrane.
  • 3. A fluid infusion device, comprising: a housing having a first chamber and a second chamber, with a seal that separates the first chamber from the second chamber, and the seal defines an opening;a fluid reservoir received within the second chamber of the housing that defines a reservoir chamber to receive a fluid, the fluid reservoir including a first end and a second end, the first end having an open perimeter and the second end terminates in a port that includes an outlet that defines a fluid flow path, the fluid reservoir including a stopper disposed in the reservoir chamber that is movable from the first end to the second end to dispense the fluid through the outlet, the stopper including at least one friction element that contacts an interior surface of the fluid reservoir, the fluid reservoir having a first pressure;a drive system received within the first chamber of the housing having a slide, a motor, a gear box and a drive screw, at least the gear box and the drive screw surrounded by the slide, the motor drives the gear box to rotate the drive screw, the slide including a plurality of threads defined on an interior surface that threadably engage threads of the drive screw such that a rotation of the drive screw by the gear box translates the slide through the opening of the seal into the second chamber, the slide received within the reservoir chamber through the first end of the fluid reservoir, the slide translatable within the reservoir chamber, the slide having a projection received within a counterbore of the stopper and a shoulder that contacts the stopper to move the stopper from the first end to the second end to dispense the fluid through the outlet;a hydrophilic wicking membrane having a first surface in contact with the fluid and an opposite second surface, the second surface coupled to the interior surface of the fluid reservoir at the second end so as to be disposed entirely within the reservoir chamber, the hydrophilic wicking membrane coupled to the second end such that the at least one friction element is spaced apart from the hydrophilic wicking membrane when the stopper is moved to the second end and the hydrophilic wicking membrane is coupled to the interior surface at the second end of the fluid reservoir to completely cover the outlet and substantially prevent a flow of air into the fluid flow path; anda reservoir cap removably coupled to the second chamber of the housing and including a connector needle received within the port such that the connector needle is downstream of the hydrophilic wicking membrane to define a fluid flow path from the fluid reservoir to a tubing, the tubing having a second pressure, the first pressure greater than the second pressure and the difference between the first pressure and the second pressure cooperates with the hydrophilic wicking membrane to dispense the fluid through the outlet.
  • 4. The fluid infusion device of claim 3, wherein the fluid is insulin and the fluid infusion device is an insulin infusion device.
  • 5. An insulin fluid infusion device, comprising: a housing having a first chamber and a second chamber, with a seal that separates the first chamber from the second chamber, and the seal defines an opening;a fluid reservoir received within the second chamber of the housing that defines a reservoir chamber to receive a fluid, the fluid reservoir including a first end and a second end, the first end having an open perimeter and the second end terminates in a port that includes an outlet to define a fluid flow path, the fluid reservoir including a stopper disposed within the reservoir chamber and movable from the first end to the second end to dispense the fluid through the outlet, the stopper including at least one friction element that contacts an interior surface of the fluid reservoir, the fluid reservoir having a first pressure;a reservoir cap coupled to the second end of the fluid reservoir that includes a connector needle received within the port downstream of a hydrophilic wicking membrane to define a fluid flow path from the fluid reservoir to a tubing coupled to an infusion unit, the tubing having a second pressure, the first pressure greater than the second pressure;a drive system received within the first chamber of the housing having a slide, a motor, a gear box and a drive screw, at least the gear box and the drive screw surrounded by the slide, the motor drives the gear box to rotate the drive screw, the slide including a plurality of threads defined on an interior surface that threadably engage threads of the drive screw such that a rotation of the drive screw by the gear box translates the slide through the opening of the seal into the second chamber, the slide received within the reservoir chamber through the first end of the fluid reservoir, the slide translatable within the reservoir chamber, the slide having a projection received within a counterbore of the stopper and a shoulder that contacts the stopper to move the stopper from the first end to the second end to dispense the fluid through the outlet; andthe hydrophilic wicking membrane having a first surface in contact with the fluid and a second surface opposite the first surface, the second surface coupled to the interior surface of the second end of the fluid reservoir so as to be disposed entirely within the reservoir chamber, the hydrophilic wicking membrane coupled to the second end such that the at least one friction element is spaced apart from the wicking hydrophilic membrane when the stopper is moved to the second end, the wicking hydrophilic membrane completely covers the outlet to substantially prevent a flow of air into the fluid flow path and the difference between the first pressure and the second pressure cooperates with the hydrophilic wicking membrane to dispense the fluid through the outlet.
  • 6. The fluid infusion device of claim 5, wherein the fluid is insulin.
  • 7. The fluid infusion device of claim 5, wherein the hydrophilic wicking membrane is coupled to the second end of the fluid reservoir such that the hydrophilic wicking membrane is spaced apart from the slide of the drive system.
US Referenced Citations (247)
Number Name Date Kind
3631847 Hobbs, II Jan 1972 A
4212738 Henne Jul 1980 A
4270532 Franetzki et al. Jun 1981 A
4282872 Franetzki et al. Aug 1981 A
4373527 Fischell Feb 1983 A
4395259 Prestele et al. Jul 1983 A
4433072 Pusineri et al. Feb 1984 A
4443218 Decant, Jr. et al. Apr 1984 A
4494950 Fischell Jan 1985 A
4542532 McQuilkin Sep 1985 A
4550731 Batina et al. Nov 1985 A
4559037 Franetzki et al. Dec 1985 A
4562751 Nason et al. Jan 1986 A
4671288 Gough Jun 1987 A
4678408 Nason et al. Jul 1987 A
4685903 Cable et al. Aug 1987 A
4731051 Fischell Mar 1988 A
4731726 Allen, III Mar 1988 A
4781798 Gough Nov 1988 A
4803625 Fu et al. Feb 1989 A
4809697 Causey, III et al. Mar 1989 A
4826810 Aoki May 1989 A
4871351 Feingold Oct 1989 A
4898578 Rubalcaba, Jr. Feb 1990 A
5003298 Havel Mar 1991 A
5011468 Lundquist et al. Apr 1991 A
5019974 Beckers May 1991 A
5050612 Matsumura Sep 1991 A
5078683 Sancoff et al. Jan 1992 A
5080653 Voss et al. Jan 1992 A
5097122 Colman et al. Mar 1992 A
5100380 Epstein et al. Mar 1992 A
5101814 Palti Apr 1992 A
5108819 Heller et al. Apr 1992 A
5114421 Polak May 1992 A
5153827 Coutre et al. Oct 1992 A
5165407 Wilson et al. Nov 1992 A
5247434 Peterson et al. Sep 1993 A
5262035 Gregg et al. Nov 1993 A
5262305 Heller et al. Nov 1993 A
5264104 Gregg et al. Nov 1993 A
5264105 Gregg et al. Nov 1993 A
5279608 Cherif Cheikh Jan 1994 A
5284140 Allen et al. Feb 1994 A
5299571 Mastrototaro Apr 1994 A
5307263 Brown Apr 1994 A
5317506 Coutre et al. May 1994 A
5320725 Gregg et al. Jun 1994 A
5322063 Allen et al. Jun 1994 A
5338157 Blomquist Aug 1994 A
5339821 Fujimoto Aug 1994 A
5341291 Roizen et al. Aug 1994 A
5350411 Ryan et al. Sep 1994 A
5356786 Heller et al. Oct 1994 A
5357427 Langen et al. Oct 1994 A
5368562 Blomquist et al. Nov 1994 A
5370622 Livingston et al. Dec 1994 A
5371687 Holmes, II et al. Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5403700 Heller et al. Apr 1995 A
5411647 Johnson et al. May 1995 A
5482473 Lord et al. Jan 1996 A
5485408 Blomquist Jan 1996 A
5505709 Funderburk et al. Apr 1996 A
5497772 Schulman et al. May 1996 A
5543326 Heller et al. Aug 1996 A
5569186 Lord et al. Oct 1996 A
5569187 Kaiser Oct 1996 A
5573506 Vasko Nov 1996 A
5582593 Hultman Dec 1996 A
5586553 Halili et al. Dec 1996 A
5593390 Castellano et al. Jan 1997 A
5593852 Heller et al. Jan 1997 A
5594638 Illiff Jan 1997 A
5609060 Dent Mar 1997 A
5626144 Tacklind et al. May 1997 A
5630710 Tune et al. May 1997 A
5643212 Coutre et al. Jul 1997 A
5660163 Schulman et al. Aug 1997 A
5660176 Iliff Aug 1997 A
5665065 Colman et al. Sep 1997 A
5665222 Heller et al. Sep 1997 A
5685844 Marttila Nov 1997 A
5687734 Dempsey et al. Nov 1997 A
5704366 Tacklind et al. Jan 1998 A
5750926 Schulman et al. May 1998 A
5754111 Garcia May 1998 A
5764159 Neftel Jun 1998 A
5772635 Dastur et al. Jun 1998 A
5779665 Mastrototaro et al. Jul 1998 A
5788669 Peterson Aug 1998 A
5791344 Schulman et al. Aug 1998 A
5800420 Gross et al. Sep 1998 A
5807336 Russo et al. Sep 1998 A
5814015 Gargano et al. Sep 1998 A
5822715 Worthington et al. Oct 1998 A
5832448 Brown Nov 1998 A
5840020 Heinonen et al. Nov 1998 A
5861018 Feierbach et al. Jan 1999 A
5868669 Iliff Feb 1999 A
5871465 Vasko Feb 1999 A
5879163 Brown et al. Mar 1999 A
5885245 Lynch et al. Mar 1999 A
5897493 Brown Apr 1999 A
5899855 Brown May 1999 A
5904708 Goedeke May 1999 A
5913310 Brown Jun 1999 A
5917346 Gord Jun 1999 A
5918603 Brown Jul 1999 A
5925021 Castellano et al. Jul 1999 A
5933136 Brown Aug 1999 A
5935099 Peterson et al. Aug 1999 A
5940801 Brown Aug 1999 A
5956501 Brown Sep 1999 A
5960403 Brown Sep 1999 A
5965380 Heller et al. Oct 1999 A
5972199 Heller et al. Oct 1999 A
5978236 Faberman et al. Nov 1999 A
5997476 Brown Dec 1999 A
5999848 Gord et al. Dec 1999 A
5999849 Gord et al. Dec 1999 A
6009339 Bentsen et al. Dec 1999 A
6032119 Brown et al. Feb 2000 A
6043437 Schulman et al. Mar 2000 A
6081736 Colvin et al. Jun 2000 A
6083710 Heller et al. Jul 2000 A
6088608 Schulman et al. Jul 2000 A
6101478 Brown Aug 2000 A
6103033 Say et al. Aug 2000 A
6119028 Schulman et al. Sep 2000 A
6120676 Heller et al. Sep 2000 A
6121009 Heller et al. Sep 2000 A
6134461 Say et al. Oct 2000 A
6143164 Heller et al. Nov 2000 A
6162611 Heller et al. Dec 2000 A
6175752 Say et al. Jan 2001 B1
6183412 Benkowski et al. Feb 2001 B1
6246992 Brown Jun 2001 B1
6259937 Schulman et al. Jul 2001 B1
6329161 Heller et al. Dec 2001 B1
6408330 DeLaHuerga Jun 2002 B1
6424847 Mastrototaro et al. Jul 2002 B1
6472122 Schulman et al. Oct 2002 B1
6484045 Holker et al. Nov 2002 B1
6484046 Say et al. Nov 2002 B1
6485465 Moberg et al. Nov 2002 B2
6503381 Gotoh et al. Jan 2003 B1
6514718 Heller et al. Feb 2003 B2
6544173 West et al. Apr 2003 B2
6553263 Meadows et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560741 Gerety et al. May 2003 B1
6565509 Say et al. May 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6591125 Buse et al. Jul 2003 B1
6592745 Feldman et al. Jul 2003 B1
6605200 Mao et al. Aug 2003 B1
6605201 Mao et al. Aug 2003 B1
6607658 Heller et al. Aug 2003 B1
6616819 Liamos et al. Sep 2003 B1
6618934 Feldman et al. Sep 2003 B1
6623501 Heller et al. Sep 2003 B2
6641533 Causey, III et al. Nov 2003 B2
6654625 Say et al. Nov 2003 B1
6659980 Moberg et al. Dec 2003 B2
6671554 Gibson et al. Dec 2003 B2
6676816 Mao et al. Jan 2004 B2
6689265 Heller et al. Feb 2004 B2
6728576 Thompson et al. Apr 2004 B2
6733471 Ericson et al. May 2004 B1
6746582 Heller et al. Jun 2004 B2
6747556 Medema et al. Jun 2004 B2
6749740 Liamos et al. Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6809653 Mann et al. Oct 2004 B1
6817990 Yap et al. Nov 2004 B2
6881551 Heller et al. Apr 2005 B2
6892085 McIvor et al. May 2005 B2
6893545 Gotoh et al. May 2005 B2
6895263 Shin et al. May 2005 B2
6916169 Rush et al. Jul 2005 B2
6932584 Gray et al. Aug 2005 B2
6932894 Mao et al. Aug 2005 B2
6942518 Liamos et al. Sep 2005 B2
7153263 Carter et al. Dec 2006 B2
7153289 Vasko Dec 2006 B2
7396330 Banet et al. Jul 2008 B2
7621893 Moberg et al. Nov 2009 B2
7828764 Moberg et al. Nov 2010 B2
7905868 Moberg et al. Mar 2011 B2
20010044731 Coffman et al. Nov 2001 A1
20020013518 West et al. Jan 2002 A1
20020055857 Mault et al. May 2002 A1
20020082665 Haller et al. Jun 2002 A1
20020093192 Matkovich Jul 2002 A1
20020137997 Mastrototaro et al. Sep 2002 A1
20020161288 Shin et al. Oct 2002 A1
20030060765 Campbell et al. Mar 2003 A1
20030078560 Miller et al. Apr 2003 A1
20030088166 Say et al. May 2003 A1
20030144581 Conn et al. Jul 2003 A1
20030152823 Heller Aug 2003 A1
20030176183 Drucker et al. Sep 2003 A1
20030188427 Say et al. Oct 2003 A1
20030199744 Buse et al. Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030220552 Reghabi et al. Nov 2003 A1
20040061232 Shah et al. Apr 2004 A1
20040061234 Shah et al. Apr 2004 A1
20040064133 Miller et al. Apr 2004 A1
20040064156 Shah et al. Apr 2004 A1
20040073095 Causey, III et al. Apr 2004 A1
20040074785 Holker et al. Apr 2004 A1
20040093167 Braig et al. May 2004 A1
20040097796 Berman et al. May 2004 A1
20040102683 Khanuja et al. May 2004 A1
20040111017 Say et al. Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040167465 Mihai et al. Aug 2004 A1
20040263354 Mann et al. Dec 2004 A1
20050038331 Silaski et al. Feb 2005 A1
20050038680 McMahon et al. Feb 2005 A1
20050154271 Rasdal et al. Jul 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20060229694 Schulman et al. Oct 2006 A1
20060238333 Welch et al. Oct 2006 A1
20060293571 Bao et al. Dec 2006 A1
20070088521 Shmueli et al. Apr 2007 A1
20070135866 Baker et al. Jun 2007 A1
20080154503 Wittenber et al. Jun 2008 A1
20080269682 Kavazov Oct 2008 A1
20080269687 Chong et al. Oct 2008 A1
20080294100 de Costa Nov 2008 A1
20090081951 Erdmann et al. Mar 2009 A1
20090082635 Baldus et al. Mar 2009 A1
20090299290 Moberg Dec 2009 A1
20110060274 Kuhn Mar 2011 A1
20120035543 Kamen Feb 2012 A1
20130253439 Wyss Sep 2013 A1
20130296825 Lerner Nov 2013 A1
20140039456 Lerner Feb 2014 A1
20140358111 Brewer Dec 2014 A1
20150018765 Wong et al. Jan 2015 A1
Foreign Referenced Citations (29)
Number Date Country
4329229 Mar 1995 DE
0319268 Nov 1988 EP
0806738 Nov 1997 EP
0880936 Dec 1998 EP
1338295 Aug 2003 EP
1631036 Mar 2006 EP
2455126 May 2012 EP
2623142 Aug 2013 EP
2218831 Nov 1989 GB
WO 9620745 Jul 1996 WO
WO 9636389 Nov 1996 WO
WO 9637246 Nov 1996 WO
WO 9721456 Jun 1997 WO
WO 9820439 May 1998 WO
WO 9824358 Jun 1998 WO
WO 9842407 Oct 1998 WO
WO 9849659 Nov 1998 WO
WO 9859487 Dec 1998 WO
WO 9908183 Feb 1999 WO
WO 9910801 Mar 1999 WO
WO 9918532 Apr 1999 WO
WO 9922236 May 1999 WO
WO 0010628 Mar 2000 WO
WO 0019887 Apr 2000 WO
WO 0048112 Aug 2000 WO
WO 02058537 Aug 2002 WO
WO 03001329 Jan 2003 WO
WO 03094090 Nov 2003 WO
WO 2005065538 Jul 2005 WO
Non-Patent Literature Citations (88)
Entry
PCT Search Report (PCT/US02/03299), dated Oct. 31, 2002, Medtronic Minimed, Inc.
(Animas Corporation, 1999). Animas . . . bringing new life to insulin therapy.
Bode B W, et al. (1996). Reduction in Severe Hypoglycemia with Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes. Diabetes Care, vol. 19, No. 4, 324-327.
Boland E (1998). Teens Pumping it Up! Insulin Pump Therapy Guide for Adolescents. 2nd Edition.
Brackenridge B P (1992). Carbohydrate Gram Counting a Key to Accurate Mealtime Boluses in Intensive Diabetes Therapy. Practical Diabetology, vol. 11, No. 2, pp. 22-28.
Brackenridge, B P et al. (1995). Counting Carbohydrates How to Zero in on Good Control. MiniMed Technologies Inc.
Farkas-Hirsch R et al. (1994). Continuous Subcutaneous Insulin Infusion: A Review of the Past and Its Implementation for the Future. Diabetes Spectrum From Research to Practice, vol. 7, No. 2, pp. 80-84, 136-138.
Hirsch I B et al. (1990). Intensive Insulin Therapy for Treatment of Type I Diabetes. Diabetes Care, vol. 13, No. 12, pp. 1265-1283.
Kulkarni K et al. (1999). Carbohydrate Counting A Primer for Insulin Pump Users to Zero in on Good Control. MiniMed Inc.
Marcus A O et al. (1996). Insulin Pump Therapy Acceptable Alternative to Injection Therapy. Postgraduate Medicine, vol. 99, No. 3, pp. 125-142.
Reed J et al. (1996). Voice of the Diabetic, vol. 11, No. 3, pp. 1-38.
Skyler J S (1989). Continuous Subcutaneous Insulin Infusion [CSII] With External Devices: Current Status. Update in Drug Delivery Systems, Chapter 13, pp. 163-183. Futura Publishing Company.
Skyler J S et al. (1995). The Insulin Pump Therapy Book Insights from the Experts. MiniMed⋅Technologies.
Strowig S M (1993). Initiation and Management of Insulin Pump Therapy. The Diabetes Educator, vol. 19, No. 1, pp. 50-60.
Walsh J, et al. (1989). Pumping Insulin: The Art of Using an Insulin Pump. Published by MiniMed⋅Technologies.
(Intensive Diabetes Management, 1995). Insulin Infusion Pump Therapy. pp. 66-78.
(MiniMed, 1996). The MiniMed 506. 7 pages. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19961111054527/www.minimed.com/files/506_pic.htm.
(MiniMed, 1997). MiniMed 507 Specifications. 2 pages. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19970124234841/www.minimed.com/files/mmn075.htm.
(MiniMed, 1996). FAQ: The Practical Things . . . pp. 1-4. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19961111054546/www.minimed.com/files/faq_pract.htm.
(MiniMed, 1997). Wanted: a Few Good Belt Clips! 1 page. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19970124234559/www.minimed.com/files/mmn002.htm.
(MiniMed Technologies, 1994). MiniMed 506 Insulin Pump User's Guide.
(MiniMed Technologies, 1994). MiniMed™ Dosage Calculator Initial Meal Bolus Guidelines / MiniMed™ Dosage Calculator Initial Basal Rate Guidelines Percentage Method. 4 pages.
(MiniMed, 1996). MiniMed™ 507 Insulin Pump User's Guide.
(MiniMed, 1997). MiniMed™ 507 Insulin Pump User's Guide.
(MiniMed, 1998). MiniMed 507C Insulin Pump User's Guide.
(MiniMed International, 1998). MiniMed 507C Insulin Pump For those who appreciate the difference.
(MiniMed inc., 1999). MiniMed 508 Flipchart Guide to Insulin Pump Therapy.
(MiniMed Inc., 1999). Insulin Pump Comparison / Pump Therapy Will Change Your Life.
(MiniMed, 2000). MiniMed® 508 User's Guide.
(MiniMed Inc., 2000). MiniMed® Now [I] Can Meal Bolus Calculator / MiniMed® Now [I] Can Correction Bolus Calculator.
(MiniMed Inc., 2000). Now [I] Can MiniMed Pump Therapy.
(MiniMed Inc., 2000). Now [I] Can MiniMed Diabetes Management.
(Medtronic MiniMed, 2002). The 508 Insulin Pump A Tradition of Excellence.
(Medtronic MiniMed, 2002). Medtronic MiniMed Meal Bolus Calculator and Correction Bolus Calculator. International Version.
Abel, P., et al., “Experience with an implantable glucose sensor as a prerequiste of an artificial beta cell,” Biomed. Biochim. Acta 43 (1984) 5, pp. 577-584.
Bindra, Dilbir S., et al., “Design and in Vitro Studies of a Needle-Type Glucose Sensor for a Subcutaneous Monitoring,” American Chemistry Society, 1991, 63, pp. 1692-1696.
Boguslavsky, Leonid, et al., “Applications of redox polymers in biosensors,” Sold State Ionics 60, 1993, pp. 189-197.
Geise, Robert J., et al., “Electropolymerized 1,3-diaminobenzene for the construction of a 1,1′-dimethylferrocene mediated glucose biosensor,” Analytica Chimica Acta, 281, 1993, pp. 467-473.
Gernet, S., et al., “A Planar Glucose Enzyme Electrode,” Sensors and Actuators, 17, 1989, pp. 537-540.
Gernet, S., et al., “Fabrication and Characterization of a Planar Electromechanical Cell and its Application as a Glucose Sensor,” Sensors and Actuators, 18, 1989, pp. 59-70.
Gorton, L., et al., “Amperometric Biosensors Based on an Apparent Direct Electron Transfer Between Electrodes and Immobilized Peroxiases,” Analyst, Aug. 1991, vol. 117, pp. 1235-1241.
Gorton, L., et al., “Amperometric Glucose Sensors Based on Immobilized Glucose-Oxidizing Enymes and Chemically Modified Electrodes,” Analytica Chimica Acta, 249, 1991, pp. 43-54.
Gough, D. A., et al., “Two-Dimensional Enzyme Electrode Sensor for Glucose,” Analytical Chemistry, vol. 57, No. 5, 1985, pp. 2351-2357.
Gregg, Brian A., et al., “Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,” Analytical Chemistry, 62, pp. 258-263.
Gregg, Brian A., et al., “Redox Polymer Films Containing Enzymes. 1. A Redox-Conducting Epoxy Cement: Synthesis, Characterization, and Electrocatalytic Oxidation of Hydroquinone,” The Journal of Physical Chemistry, vol. 95, No. 15, 1991, pp. 5970-5975.
Hashiguchi, Yasuhiro, MD, et al., “Development of a Miniaturized Glucose Monitoring System by Combining a Needle-Type Glucose Sensor With Microdialysis Sampling Method,” Diabetes Care, vol. 17, No. 5, May 1994, pp. 387-389.
Heller, Adam, “Electrical Wiring of Redox Enzymes,” Acc. Chem. Res., vol. 23, No. 5, May 1990, pp. 128-134.
Jobst, Gerhard, et al., “Thin-Film Microbiosensors for Glucose-Lactate Monitoring,” Analytical Chemistry, vol. 68, No. 18, Sep. 15, 1996, pp. 3173-3179.
Johnson, K.W., et al., “In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue,” Biosensors & Bioelectronics, 7, 1992, pp. 709-714.
Jönsson, G., et al., “An Electromechanical Sensor for Hydrogen Peroxide Based on Peroxidase Adsorbed on a Spectrographic Graphite Electrode,” Electroanalysis, 1989, pp. 465-468.
Kanapieniene, J. J., et al., “Miniature Glucose Biosensor with Extended Linearity,” Sensors and Actuators, B. 10, 1992, pp. 37-40.
Kawamori, Ryuzo, et al., “Perfect Normalization of Excessive Glucagon Responses to Intraveneous Arginine in Human Diabetes Mellitus With the Artificial Beta-Cell,” Diabetes vol. 29, Sep. 1980, pp. 762-765.
Kimura, J., et al., “An Immobilized Enzyme Membrane Fabrication Method,” Biosensors 4, 1988, pp. 41-52.
Koudelka, M., et al., “In-vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors,” Biosensors & Bioelectronics 6, 1991, pp. 31-36.
Koudelka, M., et al., “Planar Amperometric Enzyme-Based Glucose Microelectrode,” Sensors & Actuators, 18, 1989, pp. 157-165.
Mastrototaro, John J., et al., “An electroenzymatic glucose sensor fabricated on a flexible substrate,” Sensors & Actuators, B. 5, 1991, pp. 139-144.
Mastrototaro, John J., et al., “An Electroenzymatic Sensor Capable of 72 Hour Continuous Monitoring of Subcutaneous Glucose,” 14th Annual International Diabetes Federation Congress, Washington D.C., Jun. 23-28, 1991.
McKean, Brian D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors,” IEEE Transactions on Biomedical Engineering, Vo. 35, No. 7, Jul. 1988, pp. 526-532.
Monroe, D., “Novel Implantable Glucose Sensors,” ACL, Dec. 1989, pp. 8-16.
Morff, Robert J., et al., “Microfabrication of Reproducible, Economical, Electroenzymatic Glucose Sensors,” Annuaal International Conference of teh IEEE Engineering in Medicine and Biology Society, Vo. 12, No. 2, 1990, pp. 483-484.
Moussy, Francis, et al., “Performance of Subcutaneously Implanted Needle-Type Glucose Sensors Employing a Novel Trilayer Coating,” Analytical Chemistry, vol. 65, No. 15, Aug. 1, 1993, pp. 2072-2077.
Nakamoto, S., et al., “A Lift-Off Method for Patterning Enzyme-Immobilized Membranes in Multi-Biosensors,” Sensors and Actuators 13, 1988, pp. 165-172.
Nishida, Kenro, et al., “Clinical applications of teh wearable artifical endocrine pancreas with the newly designed needle-type glucose sensor,” Elsevier Sciences B.V., 1994, pp. 353-358.
Nishida, Kenro, et al., “Development of a ferrocene-mediated needle-type glucose sensor covereed with newly designd biocompatible membrane, 2-methacryloyloxyethylphosphorylcholine-co-n-butyl nethacrylate,” Medical Progress Through Technology, vol. 21, 1995, pp. 91-103.
Poitout, V., et al., “A glucose monitoring system for on line estimation oin man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue adn a wearable control unit,” Diabetologia, vol. 36, 1991, pp. 658-663.
Reach, G., “A Method for Evaluating in vivo the Functional Characteristics of Glucose Sensors,” Biosensors 2, 1986, pp. 211-220.
Shaw, G. W., et al., “In vitro testing of a simply constructed, highly stable glucose sensor suitable for implantation in diabetic patients,” Biosensors & Bioelectronics 6, 1991, pp. 401-406.
Shichiri, M., “A Needle-Type Glucose Sensor—A Valuable Tool Not Only for a Self-Blood Glucose Monitoring but for a Wearable Artifiical Pancreas,” Life Support Systems Proceedings, XI Annual Meeting ESAO, Alpbach-Innsbruck, Austria, Sep. 1984, pp. 7-9.
Shichiri, Motoaki, et al., “An artificial endocrine pancreas—problems awaiting solution for long-term clinical applications of a glucose sensor,” Frontiers Med. Biol. Engng., 1991, vol. 3, No. 4, pp. 283-292.
Shichiri, Motoaki, et al., “Closed-Loop Glycemic Control with a Wearable Artificial Endocrine Pancreas—Variations in Daily Insulin Requirements to Glycemic Response,” Diabetes, vol. 33, Dec. 1984, pp. 1200-1202.
Shichiri, Motoaki, et al., “Glycaemic Control in a Pacreatectomized Dogs with a Wearable Artificial Endocrine Pancreas,” Diabetologia, vol. 24, 1983, pp. 179-184.
Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers,” Hormone and Metabolic Research, Supplement Series vol. No. 20, 1988, pp. 17-20.
Shichiri, M., et al., “Membrane design for extending the long-life of an implantable glucose sensor,” Diab. Nutr. Metab., vol. 2, No. 4, 1989, pp. 309-313.
Shichiri, Motoaki, et al., “Normalization of the Paradoxic Secretion of Glucagon in Diabetes Who Were Controlled by the Artificial Beta Cell,” Diabetes, vol. 28, Apr. 1979, pp. 272-275.
Shichiri, Motoaki, et al., “Telemetry Glucose Monitoring Device with Needle-Type Glucose Sensor: A useful Tool for Blood Glucose Monitoring in Diabetic Individuals,” Diabetes Care, vol. 9, No. 3, May-Jun. 1986, pp. 298-301.
Shichiri, Motoaki, et al., “Wearable Artificial Endocrine Pancreas with Needle-Type Glucose Sensor,” The Lancet, Nov. 20, 1982, pp. 1129-1131.
Shichiri, Motoaki, et al., “The Wearable Artificial Endocrine Pancreas with a Needle-Type Glucose Sensor: Perfect Glycemic Control in Ambulatory Diabetes,” Acta Paediatr Jpn 1984, vol. 26, pp. 359-370.
Shinkai, Seiji, “Molecular Recognitiion of Mono- and Di-saccharides by Phenylboronic Acids in Solvent Extraction and as a Monolayer,” J. Chem. Soc., Chem. Commun., 1991, pp. 1039-1041.
Shults, Mark C., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors,” IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, Oct. 1994, pp. 937-942.
Sternberg, Robert, et al., “Study and Development of Multilayer Needle-type Enzyme-based Glucose Microsensors,” Biosensors, vol. 4, 1988, pp. 27-40.
Tamiya, E., et al., “Micro Glucose Sensors using Electron Mediators Immobilized on a Polypyrrole-Modified Electrode,” Sensors and Actuators, vol. 18, 1989, pp. 297-307.
Tsukagoshi, Kazuhiko, et al., “Specific Complexation with Mono- and Disaccharides that can be Detected by Circular Dichroism,” J. Org. Chem., vol. 56, 1991, pp. 4089-4091.
Urban, G., et al., “Miniaturized multi-enzyme biosensors integrated with pH sensors on flexible polymer carriers for in vivo applciations,” Biosensors & Bioelectronics, vol. 7, 1992, pp. 733-739.
Ubran, G., et al., “Miniaturized thin-film biosensors using covalently immobilized glucose oxidase,” Biosensors & Bioelectronics, vol. 6, 1991, pp. 555-562.
Velho, G., et al, “In vivo calibration of a subcutaneous glucose sensor for determination of subcutaneous glucose kinetics,” Diab. Nutr. Metab., vol. 3, 1988, pp. 227-233.
Wang, Joseph, et al., “Needle-Type Dual Microsensor for the Simultaneous Monitoring of Glucose and Insulin,” Analytical Chemistry, vol. 73, 2001, pp. 844-847.
Yamasaki, Yoshimitsu, et al., “Direct Measurement of Whole Blood Glucose by a Needle-Type Sensor,” Clinics Chimica Acta, vol. 93, 1989, pp. 93-98.
Yokoyama, K., “Integrated Biosensor for Glucose and Galactose,” Analytica Chimica Acta, vol. 218, 1989, pp. 137-142.
Related Publications (1)
Number Date Country
20170143914 A1 May 2017 US